FDA Adverse Event Malfunction Summary report: N

COULTER LH 750 HEMATOLOGY ANALYZER

MDR report key: 3942666 · Received July 17, 2014

Report

Report Number
1061932-2014-01677
Event Type
Malfunction
Date Received
July 17, 2014
Date of Event
June 9, 2014
Report Date
June 9, 2014
Manufacturer
BECKMAN COULTER
Product Code
GKZ
PMA / PMN Number
K011342
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) ISOLATED THE FAILURE TO A CRACKED RINSE BLOCK FITTING. THE FSE ALSO NOTED A LOOSE DRAIN BLOCK. THE FSE REPLACED THE PROBE WIPE ASSEMBLY INCLUDING THE RINSE AND DRAIN BLOCKS. THE FSE THEN VERIFIED PROBE WIPE ALIGNMENT AND DRAINAGE. SERVICE ACTIVITY PERFORMED WAS VERIFIED TO MEET THE SPECIFIED REQUIREMENTS PER ESTABLISHED PROCEDURES. THE INSTRUMENT CONFORMED TO THE MANUFACTURER'S PUBLISHED PERFORMANCE SPECIFICATIONS AND WAS RETURNED TO NORMAL OPERATION. IN CONCLUSION, THE LIKELY CAUSE OF THE EVENT IS ATTRIBUTED TO THE CRACKED RINSE BLOCK FITTING. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED SEVERAL DROPS OF A MIXTURE OF BLOOD, DILUENT, AND CLENZ SOLUTION LEAKED IN TO THE BLOOD SAMPLING VALVE (BSV) AND ON THE COUNTER TOP INVOLVING THE COULTER LH 750 HEMATOLOGY ANALYZER. THE OPERATOR WAS WEARING PERSONAL PROTECTIVE EQUIPMENT (PPE) CONSISTING OF GLOVES AND A LABORATORY COAT AND DID NOT HAVE DIRECT CONTACT WITH THE FLUID. THERE WAS NO OPERATOR INJURY OR ADVERSE EFFECT ASSOCIATED WITH THIS EVENT. NO ERRONEOUS PATIENT RESULTS WERE GENERATED. THERE WAS NO PATIENT IMPACT ASSOCIATED WITH THIS EVENT. THE FACILITY HAS AN EXPOSURE CONTROL AND RISK MANAGEMENT PLAN IN PLACE FOR BIOHAZARD MATERIAL. A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ASSESS THE INSTRUMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
418410 COULTER LH 750 HEMATOLOGY ANALYZER COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER NA NA

Patients

Seq Age Sex Outcome Treatment
1